TSPAN14: Target/Biomarker Introduction, products summarized (antibody/ADC/bispecific/antigen/ORF vector/VLP) and disease/indication/condition/MOA for drug discovery and IVD

It’s the GeneMedi’s summary page for Target/Biomarker Introduction of TSPAN14. The page also collects GeneMedi’s different modalities and formats products for TSPAN14 in therapeutics/drug discovery and IVD diagnostics, which is including antibody, ADC, bispecific, antigen, ORF vector, VLP, etc. With GeneMedi’s target-insight database-GM ITD database, the TSPAN14 target is also connected to human indications/diseases/conditions/MOA.

Target sublocation: Transmembrane Protein.

Enables enzyme binding activity. Involved in positive regulation of Notch signaling pathway; protein localization to plasma membrane; and protein maturation. Located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Target ID

GM-MP1882

Target Name

TSPAN14

Gene ID

81619

Gene Official Name

TSPAN14

Gene Alias

DC-TM4F2, TM4SF14

Protein Sub-location

Transmembrane Protein

Category

Anti-TSN14/ TSPAN14/ DC-TM4F2 antibody for FACS & in-vivo assay| GMab

Pre-made anti-TSPAN14 benchmark inhibitory monoclonal antibody(mab, blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). The anti-TSPAN14 mab is expressed and produced by mammalian cell line as a benchmark reference therapeutic antibody for biological drug discovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Filters Sort results
Reset Apply
Cat No.
Antibody Name
Format
Classified by tag
Order
Anti-TSPAN14 monoclonal antibody
mab
FACS/Biofunctional Antibody
This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.